Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
300.50
|
299.50
|
312.50
|
309.00
|
|
|
486 114 285.00
|
2 239.00
|
|
|
300.00
|
297.00
|
307.00
|
299.50
|
|
|
375 279 798.00
|
1 523.00
|
|
|
296.00
|
293.50
|
299.50
|
293.50
|
|
|
270 830 085.00
|
1 270.00
|
|
|
286.00
|
286.00
|
296.00
|
296.00
|
|
|
346 155 971.00
|
1 529.00
|
|
|
289.50
|
285.50
|
291.50
|
285.50
|
|
|
237 514 973.00
|
1 600.00
|
|
|
297.50
|
288.50
|
298.00
|
288.50
|
|
|
354 904 279.00
|
2 482.00
|
|
|
291.00
|
288.00
|
300.00
|
300.00
|
|
|
401 589 131.00
|
1 595.00
|
|
|
290.00
|
286.50
|
293.50
|
287.50
|
|
|
260 188 785.00
|
2 026.00
|
|
|
289.00
|
287.00
|
297.50
|
288.00
|
|
|
417 507 101.00
|
1 892.00
|
|
|
303.00
|
281.00
|
304.50
|
285.50
|
|
|
966 563 912.00
|
5 030.00
|
PharmaEssentia Corporation develops and distributes therapeutic products for treatment in human disease. The Company develops drugs to treat hepatitis, chronic myeloid leukemia (CML), essential thrombocythemia (ET), myeloid fibrosis (MF), polycythemia vera (PV), hepatitis and cancer.